MedPath

Cognitive behavior therapy for adults with intellectual disabilities and substance use disorders

Not Applicable
Completed
Conditions
Participants with MBID with a history of Substance Use Disorder (SUD) who were referred to an outpatient SUD treatment facility
Mental and Behavioural Disorders
Registration Number
ISRCTN16797778
Lead Sponsor
Aveleijn
Brief Summary

2019 Thesis results in https://repository.ubn.ru.nl/handle/2066/200654 (added 07/01/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria

Between June 2014 and September 2015 twenty-three participants with MBID with a history of SUD who were referred to an outpatient SUD treatment facility were included. Criteria for inclusion in this study were:
1. Dutch as a first language
2. Sufficient oral communication skills (i.e., fluent verbal speakers)
3. A mild to borderline intellectual disability (i.e., full scale IQ between 50 – 85 according to DSM-IV criteria measured by regular intelligence tests, or, when a regular intelligence test were absent the full scale IQ was estimated by the first responsible caregivers)
4. Older than 18 years of age
Participants had no restrictions in remaining in other mental health treatment that they were currently receiving (e.g. EMDR or medication management)

Exclusion Criteria

1. Non-Dutch speaking
2. Insufficient oral communication skills
3. A moderate or severe intellectual disability (i.e., full scale IQ below 50) or a normal intelligence according to DSM-IV criteria measured by regular intelligence tests, or, when a regular intelligence test were absent the full scale IQ was estimated by the first responsible caregivers)
4. Younger than 18 years of age
5. Serious psychiatric illnesses with a chance to decompensate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Feasibility of the CBT protocol in terms of acceptability and practicality:<br> 1.1. Therapists complete an acceptability questionnaire after each session. In total therapists completed 18 questionnaires per client<br> 1.2. Both clients and therapists complete a feasibility questionnaire 0 -2 weeks after ending the entire CBT+ protocol<br> 2. Preliminary effectiveness of the treatment (in terms of decreased alcohol, stimulants and cannabis use), measured with the SumID-Q at baseline (0 - 2 weeks before the start of the treatment), post-treatment (0 - 2 weeks after ending the treatment) and at 3-months follow-up<br>
Secondary Outcome Measures
NameTimeMethod
Drop-out rate during the treatment
© Copyright 2025. All Rights Reserved by MedPath